viewBraveheart Investment Group

Braveheart Investment Group bids to take full control of Paraytec

Braveheart has offered to buy the UK scientific instrument business in shares worth £111,652

Braveheart Investment Group -

Braveheart Investment Group plc (LON:BRH) has offered to buy the rest of the shares in Paraytec Limited that it does not already own.

If accepted, Braveheart will take full control of the UK scientific instrument business through the payment of £111,652 worth of shares.

Braveheart currently owns 56% of Paraytec.

The offer is open for acceptance by Paraytec shareholders until the close of business on 30 September.

York-based Paraytec develops specialist detectors for the analytical and life sciences instrumentation market. Its ActiPix technology is used for optical imaging and absorbance measurements of fluid samples flowing in capillaries or fluid flow cuvettes.

Quick facts: Braveheart Investment Group

Price: 18.2 GBX

Market: AIM
Market Cap: £5.71 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...



Braveheart's Trevor Brown details investment in 'exciting' Pharm2Farm Limited

Proactive London's Andrew Scott speaks to Braveheart Investment Group PLC's (LON:BRH) and Pharm2Farm Limited's (P2F) Gareth Cave following Braveheart's investment in the business. P2F has developed a patented process to increase the bioavailability of trace minerals in plant feeds for...

on 15/7/19

2 min read